Skip to main content

Drugs and the Liver/Gastrointestinal System

  • Chapter
  • First Online:
Pharmacological Basis of Acute Care
  • 1658 Accesses

Abstract

Liver dysfunction is common in acutely ill patients. Unlike renal dysfunction where glomerular filtration rate (GFR) can be used to guide dose adjustments, there is no corresponding parameter to gauge the degree of liver dysfunction. Drug dosages have to be adjusted based on knowledge of pharmacodynamics and pharmacokinetics in liver disease. Metabolism of drugs with high hepatic extraction ratio (HER) is mainly dependent on blood flow to the liver. With cirrhosis and portosystemic shunting, blood flow to the liver is reduced and so is metabolism of high HER drugs. Oral bioavailability is increased and dosages should be reduced to prevent accumulation. Metabolism of low HER drugs is mainly dependent on protein binding and the intrinsic metabolic capacity of the liver. Drugs which are highly protein bound have significantly higher unbound concentrations in liver dysfunction. This is due to several mechanisms – reduced synthesis of albumin and alpha-1 acid glycoprotein, accumulation of endogenous compounds such as bilirubin which interfere in plasma protein binding, and possible qualitative changes in albumin and alpha-1 acid glycoprotein. Unbound drugs are biologically active, leading to more rapid onset of action and also increased adverse effects. For water soluble drugs, ascites and edema increases the volume of distribution and larger doses may be needed. The gastrointestinal tract is subject to many changes in the acutely ill patient. Gastrointestinal motility may be reduced due to pain, hypotension, hypoxemia, sepsis or the use of drugs such as dopamine and opioids. Hypoalbuminemia in the ill patient leads to mucosal edema and impaired absorption of enteral feeds and drugs. Acutely ill patients are also at increased risk of developing stress ulcers, which may lead to clinically important bleeding. This may be prevented with the use of appropriate stress ulcer prophylactic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Further Reading

  1. Davis M. Cholestasis and endogenous opioids-liver disease and endogenous opioids pharmacokinetics. Clin Pharmacokinet. 2007;46:825–50.

    Article  CAS  PubMed  Google Scholar 

  2. Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med. 2002;30(Suppl):S351–5.

    Article  CAS  PubMed  Google Scholar 

  3. Smith L. Drug dosing considerations for the critically ill patient with liver disease. Crit Care Nurs Clin North Am. 2010;22:335e40.

    Google Scholar 

  4. Soultati A, Dourakis SP. Liver dysfunction in the intensive care unit. Ann Gastroenterol. 2005;18(1):35.

    Google Scholar 

  5. Twycross R, Pace V, Mihalyo M, Wilcock A. Acetaminophen (Paracetamol). J Pain Symptom Manage. 2013;46:747–55.

    Article  PubMed  Google Scholar 

  6. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64(12):1147–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Lian Foo M.D., M.Anaes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Foo, L.L. (2015). Drugs and the Liver/Gastrointestinal System. In: Chan, Y., Ng, K., Sim, D. (eds) Pharmacological Basis of Acute Care. Springer, Cham. https://doi.org/10.1007/978-3-319-10386-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-10386-0_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-10385-3

  • Online ISBN: 978-3-319-10386-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics